The cardiovascular safety of sodium nitroprusside in acute heart failure

Expert Opin Drug Saf. 2024 Jun;23(6):663-666. doi: 10.1080/14740338.2024.2348570. Epub 2024 Apr 29.

Authors

Pier Paolo Bocchino¹, Filippo Angelini¹, Guglielmo Gallone¹, Simone Frea¹, Gaetano Maria De Ferrari^{1

2}

Affiliations

¹ Division of Cardiology, Cardiovascular and Thoracic Department, "Citta della Salute e della Scienza" Hospital, Turin, Italy.
² Department of Medical Sciences, University of Turin, Turin, Italy.

PMID: 38661629
DOI: 10.1080/14740338.2024.2348570

No abstract available

Keywords: Sodium nitroprusside; acute heart failure; preserved ejection fraction; reduced ejection fraction; vasodilators.

Publication types

Editorial

MeSH terms

Acute Disease
Animals
Heart Failure* / chemically induced
Heart Failure* / drug therapy
Humans
Nitroprusside* / administration & dosage
Nitroprusside* / adverse effects
Vasodilator Agents / administration & dosage
Vasodilator Agents / adverse effects

Substances

Nitroprusside
Vasodilator Agents